Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Vitamin D supplementation and COVID-19 risk: a population-based, cohort study

Oristrell et al., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01639-9
Jul 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -1% Improvement Relative Risk Mortality (b) 4% Case 1% Case (b) 5% Vitamin D for COVID-19  Oristrell et al.  Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Retrospective 404,109 patients in Spain No significant difference in outcomes seen c19early.org Oristrell et al., J. Endocrinological .., Jul 2021 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 123 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 115 treatments. c19early.org
Retrospective study of cholecalciferol and calcitriol supplementation in Catalonia showing a small but significant lower risk of cases with cholecalciferol, but no significant difference for mortality, or for calcitriol supplementation. Significant benefit was found for cases, severity, and mortality in patients achieving serum vitamin D levels ≥30ng/ml.
This is the 41st of 123 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 3 septillion).
30 studies are RCTs, which show efficacy with p=0.0000032.
risk of death, 1.0% higher, RR 1.01, p = 0.91, calcifediol, univariate.
risk of death, 4.0% lower, RR 0.96, p = 0.37, cholecalciferol, univariate.
risk of case, 1.0% lower, RR 0.99, p = 0.65, NNT 3499, calcifediol, univariate.
risk of case, 5.0% lower, RR 0.95, p = 0.004, cholecalciferol, multivariate.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Oristrell et al., 17 Jul 2021, retrospective, population-based cohort, Spain, peer-reviewed, 8 authors, dosage varies (calcifediol).
This PaperVitamin DAll
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study
J Oristrell, J C Oliva, E Casado, I Subirana, D Domínguez, A Toloba, A Balado, M Grau
Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01639-9
Purpose To analyze the associations between cholecalciferol or calcifediol supplementation, serum 25-hydroxyvitamin D (25OHD) levels and COVID-19 outcomes in a large population. Methods All individuals ≥ 18 years old living in Barcelona-Central Catalonia (n = 4.6 million) supplemented with cholecalciferol or calcifediol from April 2019 to February 2020 were compared with propensity score-matched untreated controls. Outcome variables were SARS-CoV2 infection, severe COVID-19 and COVID-19 mortality occuring during the first wave of the pandemic. Demographical data, comorbidities, serum 25OHD levels and concomitant pharmacological treatments were collected as covariates. Associations between cholecalciferol or calcifediol use and outcome variables were analyzed using multivariate Cox proportional regression. Results Cholecalciferol supplementation (n = 108,343) was associated with slight protection from SARS-CoV2 infection (n = 4352 [4.0%] vs 9142/216,686 [4.2%] in controls; HR 0.95 [CI 95% 0.91-0.98], p = 0.004). Patients on cholecalciferol treatment achieving 25OHD levels ≥ 30 ng/ml had lower risk of SARS-CoV2 infection, lower risk of severe COVID-19 and lower COVID-19 mortality than unsupplemented 25OHD-deficient patients (56/9474 [0.6%] vs 96/7616 [1.3%]; HR 0.66 [CI 95% 0.46-0.93], p = 0.018). Calcifediol use (n = 134,703) was not associated with reduced risk of SARS-CoV2 infection or mortality in the whole cohort. However, patients on calcifediol treatment achieving serum 25OHD levels ≥ 30 ng/ml also had lower risk of SARS-CoV2 infection, lower risk of severe COVID-19, and lower COVID-19 mortality compared to 25OHD-deficient patients not receiving vitamin D supplements (88/16276 [0.5%] vs 96/7616 [1.3%]; HR 0.56 [CI 95% 0.42-0.76], p < 0.001). Conclusions In this large, population-based study, we observed that patients supplemented with cholecalciferol or calcifediol achieving serum 25OHD levels ≥ 30 ng/ml were associated with better COVID-19 outcomes.
Discussion In this large population-based cohort, we have compared COVID-19 outcomes in patients supplemented with cholecalciferol or calcifediol versus untreated matched controls, finding only a mild reduction in the risk of SARS-CoV2 infection (diagnosed clinically or by PCR) in patients supplemented with cholecalciferol, and a small reduction in Declarations Conflicts of interest The authors declare no conflict of interest. The Catalan Agency for Health Quality and Evaluation (AQUAS), a governmental office, offered a data analyst for extracting all the data necessary for the development of this project. They had no role in the design of the study, analyses, interpretation of data; in the writing of the manuscript, or in the decision to publish these results. Institutional review board statement This study was approved by the Institutional Ethics Committee of the Corporació Sanitària Parc Taulí-Universitat Autònoma Barcelona (Project number 2020588). Informed consent Not applicable. Patient and public involvement It was not appropriate or possible to involve patients or the public in the design, or conduct, or reporting, or dissemination plans of our research. Transparency statement The lead author (J. Oristrell) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported. No important aspects of the study have been omitted, and there were no significant discrepancies from the study as it was planned. Dissemination..
References
Abrishami, Dalili, Torbati, Asgari, Arab-Ahmadi et al., Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study, Eur J Nutr, doi:10.1007/s00394-020-02411-0
Annweiler, Corvaisier, Gautier, Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study, Nutrients
Armaly, Kinaneh, Skorecki, Renal manifestations of COVID-19: physiology and pathophysiology, J Clin Med, doi:10.3390/jcm10061216
Bassatne, Basbous, Chakhtoura, El Zein, Rahme et al., The link between COVID-19 and vitamin D (VIVID): a systematic review and meta-analysis, Metab Clin Exp
Bergman, Lindh, Björkhem-Bergman, Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials, PLoS ONE
Brunette, Chan, Ferriere, Roberts, Site of 1,25(OH)2 vitamin D3 synthesis in the kidney, Nature
Bscheider, Butcher, Vitamin D immunoregulation through dendritic cells, Immunology, doi:10.1111/imm.12610
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available tehrapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study, J Steroid Biochem Mol Biol
Cereda, Bogliolo, Lobascio, Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy, Nutrition, doi:10.1016/j.nut.2020.111055
Dancer, Parekh, Lax, Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax, doi:10.1136/thoraxjnl-2014-206680
Dusso, Tokumoto, Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease, Kidney Int
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients, doi:10.3390/nu12040988
Greiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients, doi:10.3390/nu7064240
Haussler, Professor, Jurutka, Vitamin D receptor (VDR)-mediated actions of 1α,25(OH) 2 vitamin D 3 : genomic and non-genomic mechanisms, Best Pract Res Clin Endocrinol Metab
Hernández, Nan, Fernández-Ayala, García-Unzueta, Hernández-Hernández et al., Vitamin D status in hospitalized patients with SARS-CoV2 infection, J Clin Endocrinol Metab, doi:10.1210/clinem/dgaa733
Hilger, Friedel, Herr, Rausch, Roos et al., A systematic review of vitamin D status in populations worldwide, Br J Nutr, doi:10.1017/S0007114513001840
Kassambara, Kosinski, Biecek, Survminer: drawing survival curves using 'ggplot2
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS ONE, doi:10.1371/journal.pone.0239252
Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of vitamin D status with SARS-CoV2 infection or COVID-19 severity: a systematic review and meta-analysis, Adv Nutr, doi:10.1093/advances/nmab012
Kong, Zhu, Shi, VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system, Mol Endocrinol, doi:10.1210/me.2013-1146
Kongsbak, Levring, Geisler, Von Essen Mr, The vitamin D receptor an T cell function, Front Immunol
Lely, Hamming, Van Goor, Navis, Renal ACE2 expression in human kidney disease, J Pathol
Levey, Stevens, Schmid, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate, Ann Intern Med
Ling, Broad, Murphy, Pappachan, Pardesi-Newton et al., High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study, Nutrients, doi:10.3390/nu12123799
Loucera, Peña-Chilet, Medina, Muñoyerro-Muñiz, Villegas et al., Real-world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients, doi:10.1101/2021.04.27.21255937
Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people, J Nutr
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D status and other clinical characteristics with COVID-19 test results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.19722
Merzon, Tworowski, Gorohovski, Vinker, Cohen, Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli populationbased study, FEBS J, doi:10.1111/febs.15495
Murai, Fernandes, Sales, Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19. A randomized clinical trial, JAMA, doi:10.1001/jama.2020.26848
Oristrell, Oliva, Subirana, Casado, Domínguez et al., Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease:a population-based study, Biomedicines, doi:10.3390/biomedicines9050509
Peelen, Knippenberg, Muris, Thewissen, Smolders et al., Effects of vitamin D on the peripheral adaptive immune system: a review, Autoimmun Rev
Pereira, Damascena, Azevedo, De Almeida, Da Mota, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr, doi:10.1080/10408398.2020.1841090
Pérez Castrillón, Casado, Gudino, COVID-19 and vitamin D. Position paper of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM), Rev Osteoporos Metab Miner
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients, doi:10.3390/nu12092757
Rastogi, Bhansali, Khare, Short term, highdose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgrad Med J, doi:10.1136/postgradmedj-2020-139065
Sekhon, Multivariate and propensity score matching software with automated balance Optimization: the matching package for R, J Stat Soft
Teymoori-Rad, Marashi, Vitamin D and COVID-19: from potential therapeutic effects to unanswered qüestions, Rev Med Virol, doi:10.1002/rmv.2159
Therneau, A package for survival analysis in R. R package version 3
Werion, Belkhir, Perrot, Schmit, Aydin et al., SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule, Kidney Int
Williamson, Walker, Bhaskaran, Factors associated with COVID-19-related death using OpenSAFELY, Nature
Xu, Yang, Chen, Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the reninangiotensin system, Mol Med Rep, doi:10.3892/mmr.2017.7546
Yoshida, Bohn, Package 'tableone' for R
DOI record: { "DOI": "10.1007/s40618-021-01639-9", "ISSN": [ "1720-8386" ], "URL": "http://dx.doi.org/10.1007/s40618-021-01639-9", "alternative-id": [ "1639" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "28 June 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "12 July 2021" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "17 July 2021" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflicts of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors declare no conflict of interest. The Catalan Agency for Health Quality and Evaluation (AQUAS), a governmental office, offered a data analyst for extracting all the data necessary for the development of this project. They had no role in the design of the study, analyses, interpretation of data; in the writing of the manuscript, or in the decision to publish these results." }, { "group": { "label": "Institutional review board statement", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "This study was approved by the Institutional Ethics Committee of the Corporació Sanitària Parc Taulí—Universitat Autònoma Barcelona (Project number 2020588)." }, { "group": { "label": "Informed consent", "name": "EthicsHeading" }, "name": "Ethics", "order": 4, "value": "Not applicable." }, { "group": { "label": "Patient and public involvement", "name": "EthicsHeading" }, "name": "Ethics", "order": 5, "value": "It was not appropriate or possible to involve patients or the public in the design, or conduct, or reporting, or dissemination plans of our research." }, { "group": { "label": "Transparency statement", "name": "EthicsHeading" }, "name": "Ethics", "order": 6, "value": "The lead author (J. Oristrell) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported. No important aspects of the study have been omitted, and there were no significant discrepancies from the study as it was planned." }, { "group": { "label": "Dissemination declaration", "name": "EthicsHeading" }, "name": "Ethics", "order": 7, "value": "Dissemination to the patients supplemented with vitamin D compounts is not applicable." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-1486-3192", "affiliation": [], "authenticated-orcid": false, "family": "Oristrell", "given": "J.", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0003-1273-2746", "affiliation": [], "authenticated-orcid": false, "family": "Oliva", "given": "J. C.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-8839-6430", "affiliation": [], "authenticated-orcid": false, "family": "Casado", "given": "E.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1676-0197", "affiliation": [], "authenticated-orcid": false, "family": "Subirana", "given": "I.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-0258-6194", "affiliation": [], "authenticated-orcid": false, "family": "Domínguez", "given": "D.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1681-2946", "affiliation": [], "authenticated-orcid": false, "family": "Toloba", "given": "A.", "sequence": "additional" }, { "affiliation": [], "family": "Balado", "given": "A.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-2807-8136", "affiliation": [], "authenticated-orcid": false, "family": "Grau", "given": "M.", "sequence": "additional" } ], "container-title": "Journal of Endocrinological Investigation", "container-title-short": "J Endocrinol Invest", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2021, 7, 17 ] ], "date-time": "2021-07-17T05:02:27Z", "timestamp": 1626498147000 }, "deposited": { "date-parts": [ [ 2022, 1, 7 ] ], "date-time": "2022-01-07T19:17:19Z", "timestamp": 1641583039000 }, "indexed": { "date-parts": [ [ 2024, 3, 30 ] ], "date-time": "2024-03-30T19:48:07Z", "timestamp": 1711828087985 }, "is-referenced-by-count": 85, "issue": "1", "issued": { "date-parts": [ [ 2021, 7, 17 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2022, 1 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 17 ] ], "date-time": "2021-07-17T00:00:00Z", "timestamp": 1626480000000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 17 ] ], "date-time": "2021-07-17T00:00:00Z", "timestamp": 1626480000000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s40618-021-01639-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s40618-021-01639-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s40618-021-01639-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "167-179", "prefix": "10.1007", "published": { "date-parts": [ [ 2021, 7, 17 ] ] }, "published-online": { "date-parts": [ [ 2021, 7, 17 ] ] }, "published-print": { "date-parts": [ [ 2022, 1 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.3390/nu12040988", "author": "WB Grant", "doi-asserted-by": "publisher", "first-page": "988", "journal-title": "Nutrients", "key": "1639_CR1", "unstructured": "Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12:988. https://doi.org/10.3390/nu12040988", "volume": "12", "year": "2020" }, { "DOI": "10.1002/rmv.2159", "author": "M Teymoori-Rad", "doi-asserted-by": "publisher", "journal-title": "Rev Med Virol", "key": "1639_CR2", "unstructured": "Teymoori-Rad M, Marashi SM (2020) Vitamin D and COVID-19: from potential therapeutic effects to unanswered qüestions. Rev Med Virol. https://doi.org/10.1002/rmv.2159", "year": "2020" }, { "DOI": "10.1017/S0007114513001840", "author": "J Hilger", "doi-asserted-by": "publisher", "first-page": "23", "journal-title": "Br J Nutr", "key": "1639_CR3", "unstructured": "Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA et al (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111:23–45. https://doi.org/10.1017/S0007114513001840", "volume": "111", "year": "2014" }, { "DOI": "10.1016/j.autrev.2011.05.002", "author": "E Peelen", "doi-asserted-by": "publisher", "first-page": "733", "journal-title": "Autoimmun Rev", "key": "1639_CR4", "unstructured": "Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Cohen Tervaert JW et al (2011) Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10:733–743", "volume": "10", "year": "2011" }, { "DOI": "10.3389/fimmu.2013.00148", "author": "M Kongsbak", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Front Immunol", "key": "1639_CR5", "unstructured": "Kongsbak M, Levring TB, Geisler C, von Essen MR (2013) The vitamin D receptor an T cell function. Front Immunol 4:1–10", "volume": "4", "year": "2013" }, { "DOI": "10.1111/imm.12610", "author": "M Bscheider", "doi-asserted-by": "publisher", "first-page": "227", "journal-title": "Immunology", "key": "1639_CR6", "unstructured": "Bscheider M, Butcher EC (2016) Vitamin D immunoregulation through dendritic cells. Immunology 148:227–236. https://doi.org/10.1111/imm.12610", "volume": "148", "year": "2016" }, { "DOI": "10.1371/journal.pone.0065835", "author": "P Bergman", "doi-asserted-by": "publisher", "first-page": "e65835", "journal-title": "PLoS ONE", "key": "1639_CR7", "unstructured": "Bergman P, Lindh AU, Björkhem-Bergman L et al (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 8:e65835", "volume": "8", "year": "2013" }, { "DOI": "10.1136/bmj.i6583", "author": "AR Martineau", "doi-asserted-by": "publisher", "first-page": "i6583", "journal-title": "BMJ", "key": "1639_CR8", "unstructured": "Martineau AR, Jolliffe DA, Hooper RL et al (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356:i6583", "volume": "356", "year": "2017" }, { "DOI": "10.4321/S1889-836X2020000400009", "author": "JL Pérez Castrillón", "doi-asserted-by": "publisher", "first-page": "155", "journal-title": "Rev Osteoporos Metab Miner", "key": "1639_CR9", "unstructured": "Pérez Castrillón JL, Casado E, Corral Gudino L et al (2020) COVID-19 and vitamin D. Position paper of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM). Rev Osteoporos Metab Miner 12:155–159", "volume": "12", "year": "2020" }, { "DOI": "10.1371/journal.pone.0239252", "author": "HW Kaufman", "doi-asserted-by": "publisher", "first-page": "e0239252", "journal-title": "PLoS ONE", "key": "1639_CR10", "unstructured": "Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF (2020) SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15:e0239252. https://doi.org/10.1371/journal.pone.0239252", "volume": "15", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2020.19722", "author": "DO Meltzer", "doi-asserted-by": "publisher", "first-page": "e2019722", "issue": "9", "journal-title": "JAMA Netw Open", "key": "1639_CR11", "unstructured": "Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J (2020) Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open 3(9):e2019722. https://doi.org/10.1001/jamanetworkopen.2020.19722", "volume": "3", "year": "2020" }, { "DOI": "10.1111/febs.15495", "author": "E Merzon", "doi-asserted-by": "publisher", "journal-title": "FEBS J", "key": "1639_CR12", "unstructured": "Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A et al (2020) Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. https://doi.org/10.1111/febs.15495", "year": "2020" }, { "DOI": "10.3390/nu12092757", "author": "A Radujkovic", "doi-asserted-by": "publisher", "first-page": "2757", "journal-title": "Nutrients", "key": "1639_CR13", "unstructured": "Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U (2020) Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 12:2757. https://doi.org/10.3390/nu12092757", "volume": "12", "year": "2020" }, { "DOI": "10.1007/s00394-020-02411-0", "author": "A Abrishami", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Eur J Nutr", "key": "1639_CR14", "unstructured": "Abrishami A, Dalili N, Torbati PM, Asgari R, Arab-Ahmadi M, Behnam B et al (2020) Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study. Eur J Nutr 30:1–9. https://doi.org/10.1007/s00394-020-02411-0", "volume": "30", "year": "2020" }, { "DOI": "10.1093/jn/nxaa332", "author": "X Luo", "doi-asserted-by": "publisher", "first-page": "98", "journal-title": "J Nutr", "key": "1639_CR15", "unstructured": "Luo X, Liao Q, Shen Y, Li H, Cheng L (2021) Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. J Nutr 151:98–103", "volume": "151", "year": "2021" }, { "DOI": "10.1016/j.metabol.2021.154753", "author": "A Bassatne", "doi-asserted-by": "publisher", "first-page": "154753", "journal-title": "Metab Clin Exp", "key": "1639_CR16", "unstructured": "Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj FG (2021) The link between COVID-19 and vitamin D (VIVID): a systematic review and meta-analysis. Metab Clin Exp 119:154753", "volume": "119", "year": "2021" }, { "DOI": "10.1093/advances/nmab012", "author": "A Kazemi", "doi-asserted-by": "publisher", "journal-title": "Adv Nutr", "key": "1639_CR17", "unstructured": "Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CCT, Babajafari S (2021) Association of vitamin D status with SARS-CoV2 infection or COVID-19 severity: a systematic review and meta-analysis. Adv Nutr. https://doi.org/10.1093/advances/nmab012", "year": "2021" }, { "DOI": "10.1080/10408398.2020.1841090", "author": "M Pereira", "doi-asserted-by": "publisher", "journal-title": "Crit Rev Food Sci Nutr", "key": "1639_CR18", "unstructured": "Pereira M, Dantas Damascena A, Galvão Azevedo LM, de Almeida OT, da Mota SJ (2020) Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2020.1841090", "year": "2020" }, { "DOI": "10.1210/clinem/dgaa733", "author": "JL Hernández", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "J Clin Endocrinol Metab", "key": "1639_CR19", "unstructured": "Hernández JL, Nan D, Fernández-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M et al (2020) Vitamin D status in hospitalized patients with SARS-CoV2 infection. J Clin Endocrinol Metab 20:1–11. https://doi.org/10.1210/clinem/dgaa733", "volume": "20", "year": "2020" }, { "DOI": "10.3390/nu12113377", "author": "G Annweiler", "doi-asserted-by": "publisher", "first-page": "3377", "journal-title": "Nutrients", "key": "1639_CR20", "unstructured": "Annweiler G, Corvaisier M, Gautier J et al (2020) Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients 12:3377", "volume": "12", "year": "2020" }, { "DOI": "10.3390/nu12123799", "author": "SF Ling", "doi-asserted-by": "publisher", "first-page": "3799", "journal-title": "Nutrients", "key": "1639_CR21", "unstructured": "Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF et al (2020) High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients 12:3799. https://doi.org/10.3390/nu12123799", "volume": "12", "year": "2020" }, { "DOI": "10.1016/j.nut.2020.111055", "author": "E Cereda", "doi-asserted-by": "publisher", "journal-title": "Nutrition", "key": "1639_CR22", "unstructured": "Cereda E, Bogliolo L, Lobascio F et al (2019) Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy. Nutrition 2020:111055. https://doi.org/10.1016/j.nut.2020.111055", "volume": "2020", "year": "2019" }, { "DOI": "10.1016/j.jsbmb.2020.105751", "author": "M Entrenas Castillo", "doi-asserted-by": "publisher", "first-page": "105751", "journal-title": "J Steroid Biochem Mol Biol", "key": "1639_CR23", "unstructured": "Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM et al (2020) Effect of calcifediol treatment and best available tehrapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751", "volume": "203", "year": "2020" }, { "DOI": "10.1136/postgradmedj-2020-139065", "author": "A Rastogi", "doi-asserted-by": "publisher", "journal-title": "Postgrad Med J", "key": "1639_CR24", "unstructured": "Rastogi A, Bhansali A, Khare N et al (2020) Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. https://doi.org/10.1136/postgradmedj-2020-139065", "year": "2020" }, { "DOI": "10.1001/jama.2020.26848", "author": "IH Murai", "doi-asserted-by": "publisher", "journal-title": "JAMA", "key": "1639_CR25", "unstructured": "Murai IH, Fernandes AL, Sales LP et al (2021) Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19. A randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2020.26848", "year": "2021" }, { "DOI": "10.3390/biomedicines9050509", "author": "J Oristrell", "doi-asserted-by": "publisher", "first-page": "509", "journal-title": "Biomedicines", "key": "1639_CR26", "unstructured": "Oristrell J, Oliva JC, Subirana I, Casado E, Domínguez D, Toloba A et al (2021) Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease:a population-based study. Biomedicines 9:509. https://doi.org/10.3390/biomedicines9050509", "volume": "9", "year": "2021" }, { "DOI": "10.1038/s41586-020-2521-4", "author": "EJ Williamson", "doi-asserted-by": "publisher", "first-page": "430", "journal-title": "Nature", "key": "1639_CR27", "unstructured": "Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430–443", "volume": "584", "year": "2020" }, { "DOI": "10.18637/jss.v042.i07", "author": "JS Sekhon", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "J Stat Soft", "key": "1639_CR28", "unstructured": "Sekhon JS (2011) Multivariate and propensity score matching software with automated balance Optimization: the matching package for R. J Stat Soft 42:1–52", "volume": "42", "year": "2011" }, { "DOI": "10.7326/0003-4819-150-9-200905050-00006", "author": "AS Levey", "doi-asserted-by": "publisher", "first-page": "604", "journal-title": "Ann Intern Med", "key": "1639_CR29", "unstructured": "Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612", "volume": "150", "year": "2009" }, { "key": "1639_CR30", "unstructured": "Yoshida K, Bohn J. Package ‘tableone’ for R. Accessible online at https://cran.r-project.org/web/packages/tableone/tableone.pdf" }, { "key": "1639_CR31", "unstructured": "Therneau T (2020) A package for survival analysis in R. R package version 3.2-7, https://CRAN.R-project.org/package=survival" }, { "key": "1639_CR32", "unstructured": "Kassambara A, Kosinski M, Biecek P et al. Survminer: drawing survival curves using 'ggplot2', https://CRAN.R-project.org/package=survminer" }, { "DOI": "10.1038/ki.2010.543", "author": "AS Dusso", "doi-asserted-by": "publisher", "first-page": "715", "journal-title": "Kidney Int", "key": "1639_CR33", "unstructured": "Dusso AS, Tokumoto M (2011) Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int 79:715–729", "volume": "79", "year": "2011" }, { "DOI": "10.3390/nu7064240", "author": "CL Greiller", "doi-asserted-by": "publisher", "first-page": "4240", "journal-title": "Nutrients", "key": "1639_CR34", "unstructured": "Greiller CL, Martineau AR (2015) Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 7:4240–4270. https://doi.org/10.3390/nu7064240", "volume": "7", "year": "2015" }, { "DOI": "10.1210/me.2013-1146", "author": "J Kong", "doi-asserted-by": "publisher", "first-page": "2116", "journal-title": "Mol Endocrinol", "key": "1639_CR35", "unstructured": "Kong J, Zhu X, Shi Y et al (2013) VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol 27:2116–2125. https://doi.org/10.1210/me.2013-1146", "volume": "27", "year": "2013" }, { "DOI": "10.1136/thoraxjnl-2014-206680", "author": "RCA Dancer", "doi-asserted-by": "publisher", "first-page": "617", "journal-title": "Thorax", "key": "1639_CR36", "unstructured": "Dancer RCA, Parekh D, Lax S et al (2015) Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 70:617–624. https://doi.org/10.1136/thoraxjnl-2014-206680", "volume": "70", "year": "2015" }, { "DOI": "10.3892/mmr.2017.7546", "author": "J Xu", "doi-asserted-by": "publisher", "first-page": "7432", "journal-title": "Mol Med Rep", "key": "1639_CR37", "unstructured": "Xu J, Yang J, Chen J et al (2017) Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16:7432–7438. https://doi.org/10.3892/mmr.2017.7546", "volume": "16", "year": "2017" }, { "DOI": "10.1101/2021.04.27.21255937", "author": "C Loucera", "doi-asserted-by": "publisher", "journal-title": "MedRxiv Preprint", "key": "1639_CR38", "unstructured": "Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, López-Miranda J et al (2021) Real-world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients. MedRxiv Preprint. https://doi.org/10.1101/2021.04.27.21255937", "year": "2021" }, { "DOI": "10.1016/j.beem.2011.05.010", "author": "MR Haussler", "doi-asserted-by": "publisher", "first-page": "543", "journal-title": "Best Pract Res Clin Endocrinol Metab", "key": "1639_CR39", "unstructured": "Haussler MR, Professor R, Jurutka PW et al (2011) Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25:543–559", "volume": "25", "year": "2011" }, { "DOI": "10.1038/276287a0", "author": "MG Brunette", "doi-asserted-by": "publisher", "first-page": "287", "journal-title": "Nature", "key": "1639_CR40", "unstructured": "Brunette MG, Chan M, Ferriere C, Roberts KD (1978) Site of 1,25(OH)2 vitamin D3 synthesis in the kidney. Nature 276:287–289", "volume": "276", "year": "1978" }, { "DOI": "10.1002/path.1670", "author": "AT Lely", "doi-asserted-by": "publisher", "first-page": "587", "journal-title": "J Pathol", "key": "1639_CR41", "unstructured": "Lely AT, Hamming I, van Goor H, Navis GJ (2004) Renal ACE2 expression in human kidney disease. J Pathol 204:587–593", "volume": "204", "year": "2004" }, { "DOI": "10.1016/j.kint.2020.07.019", "author": "A Werion", "doi-asserted-by": "publisher", "first-page": "1296", "journal-title": "Kidney Int", "key": "1639_CR42", "unstructured": "Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z et al (2020) SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int 98:1296–1307", "volume": "98", "year": "2020" }, { "DOI": "10.3390/jcm10061216", "author": "Z Armaly", "doi-asserted-by": "publisher", "first-page": "1216", "journal-title": "J Clin Med", "key": "1639_CR43", "unstructured": "Armaly Z, Kinaneh S, Skorecki K (2021) Renal manifestations of COVID-19: physiology and pathophysiology. J Clin Med 10:1216. https://doi.org/10.3390/jcm10061216", "volume": "10", "year": "2021" } ], "reference-count": 43, "references-count": 43, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s40618-021-01639-9" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Endocrinology", "Endocrinology, Diabetes and Metabolism" ], "subtitle": [], "title": "Vitamin D supplementation and COVID-19 risk: a population-based, cohort study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "45" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit